Literature DB >> 28893329

Epidemiology of psychotic depression - systematic review and meta-analysis.

E Jääskeläinen1, T Juola1, H Korpela1, H Lehtiniemi1, M Nietola2, J Korkeila3, J Miettunen1.   

Abstract

Large amount of data have been published on non-psychotic depression (NPD), schizophrenia (SZ), and bipolar disorder, while psychotic depression (PD) as an own entity has received much smaller attention. We performed a systematic review and meta-analyses on epidemiology, especially incidence and prevalence, risk factors, and outcomes of PD. A systematic search to identify potentially relevant studies was conducted using four electronic databases and a manual search. The search identified 1764 unique potentially relevant articles, the final study included 99 articles. We found that the lifetime prevalence of PD varies between 0.35% and 1%, with higher rates in older age. Onset age of PD was earlier than that of NPD in younger samples, but later in older samples. There were no differences in gender distribution in PD v. NPD, but higher proportion of females was found in PD than in SZ or in psychotic bipolar disorder (PBD). Risk factors have rarely been studied, the main finding being that family history of psychosis and bipolar disorder increases the risk of PD. Outcomes of PD were mostly worse when compared with NPD, but better compared with SZ and schizoaffective disorder. The outcome compared with PBD was relatively similar, and somewhat varied depending on the measure of the outcome. Based on this review, the amount of research on PD is far from that of NPD, SZ, and bipolar disorder. Based on our findings, PD seems distinguishable from related disorders and needs more scientific attention.

Entities:  

Keywords:  Epidemiology; incidence; major depressive disorder; outcome; prognosis; psychosis; psychotic depression; psychotic disorders; risk; unipolar depression

Mesh:

Year:  2017        PMID: 28893329     DOI: 10.1017/S0033291717002501

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  18 in total

Review 1.  Dilemmas in the treatment of early-onset first-episode psychosis.

Authors:  Daniel Hayes; Marinos Kyriakopoulos
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-26

2.  A Load to Find Clinically Useful Biomarkers for Depression.

Authors:  Matea Nikolac Perkovic; Marina Sagud; Lucija Tudor; Marcela Konjevod; Dubravka Svob Strac; Nela Pivac
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Excess tau PET ligand retention in elderly patients with major depressive disorder.

Authors:  Sho Moriguchi; Keisuke Takahata; Hitoshi Shimada; Manabu Kubota; Soichiro Kitamura; Yasuyuki Kimura; Kenji Tagai; Ryosuke Tarumi; Hajime Tabuchi; Jeffrey H Meyer; Masaru Mimura; Kazunori Kawamura; Ming-Rong Zhang; Shigeo Murayama; Tetsuya Suhara; Makoto Higuchi
Journal:  Mol Psychiatry       Date:  2020-07-01       Impact factor: 15.992

4.  Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017.

Authors:  Johanna Seifert; Hannah B Maier; Fabienne Führmann; Stefan Bleich; Susanne Stübner; Marcel Sieberer; Xueqiong Bernegger; Waldemar Greil; Cornelius Schüle; Sermin Toto; Renate Grohmann; Matthias A Reinhard
Journal:  J Neural Transm (Vienna)       Date:  2022-05-07       Impact factor: 3.850

5.  Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II Study.

Authors:  Alastair J Flint; Anthony J Rothschild; Ellen M Whyte; George S Alexopoulos; Benoit H Mulsant; Patricia Marino; Samprit Banerjee; Cristina D Pollari; Yiyuan Wu; Aristotle N Voineskos; Barnett S Meyers
Journal:  Am J Geriatr Psychiatry       Date:  2020-11-15       Impact factor: 7.996

6.  Structural brain networks in remitted psychotic depression.

Authors:  Nicholas H Neufeld; Antonia N Kaczkurkin; Aristeidis Sotiras; Benoit H Mulsant; Erin W Dickie; Alastair J Flint; Barnett S Meyers; George S Alexopoulos; Anthony J Rothschild; Ellen M Whyte; Linda Mah; Jay Nierenberg; Matthew J Hoptman; Christos Davatzikos; Theodore D Satterthwaite; Aristotle N Voineskos
Journal:  Neuropsychopharmacology       Date:  2020-02-28       Impact factor: 8.294

7.  Psychotic Features Abated with Vitamin D Treatment in a Patient with Major Depressive Disorder.

Authors:  David C Fipps; Elisabet Rainey
Journal:  Case Rep Psychiatry       Date:  2020-06-19

8.  Association between severity of depressive symptoms and chronic knee pain in Korean adults aged over 50 years: a cross-sectional study using nationally representative data.

Authors:  Su-Bin Han; Sook-Hyun Lee; In-Hyuk Ha; Eun-Jung Kim
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

9.  Environmental Risk Factors in Bipolar Disorder and Psychotic Depression: A Systematic Review and Meta-Analysis of Prospective Studies.

Authors:  Victoria Rodriguez; Luis Alameda; Giulia Trotta; Edoardo Spinazzola; Paolo Marino; Sandra L Matheson; Kristin R Laurens; Robin M Murray; Evangelos Vassos
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

10.  Pattern of inpatient care for depression: an analysis of 232,289 admissions.

Authors:  Gernot Fugger; Thomas Waldhör; Barbara Hinterbuchinger; Nathalie Pruckner; Daniel König; Andrea Gmeiner; Sandra Vyssoki; Benjamin Vyssoki; Matthäus Fellinger
Journal:  BMC Psychiatry       Date:  2020-07-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.